XENE · earnings call history
Xenon Pharmaceuticals Q2 FY26 — Azetukalner NDA Submission and Pipeline Advancement
Read the briefXenon Pharmaceuticals Q1 FY26 — Strong X-TOLE2 Data and Extended Cash Runway
Read the briefBrowse all US companies on the earnings-call register.